L’evasione come forma simbolica. Tre diverse prospettive di vie di fuga
2013-01-01 Rossi, A
Natività a confronto: un’invenzione di Paolo De Matteis e non di Ludovico Antonio David
2007-01-01 Rossi, A
Per il ciclo di Santa Caterina al Collegio dei Nobili di Parma. Documenti e note su Francesco Stringa
2011-01-01 Rossi, A; Fogliani, I
Francesco Stringa e i miracoli di san Contardo d’Este
2014-01-01 Rossi, A
Il lato luminoso dell’errare. Sull’ostinarsi come forma di resilienza dinamica
2014-01-01 Rossi, A
La fiaccola e la maschera: didascalie in immagini per il pensiero. Un esemplare pendant di Paolo De Matteis
2015-01-01 Rossi, A
La pittura in cui abitano le ombre. Nota sulla pittura ‘figurale’ di Gianantonio Gennari
2012-01-01 Rossi, A
Exploring the concept of centralization of surgery for benign esophageal diseases: a Delphi based consensus from the European Society for Diseases of the Esophagus
2021-01-01 Lugaresi, Marialuisa; Nafteux, Philippe; Nilsson, Magnus; Reynolds, John V; Rosati, Riccardo; Schoppmann, Sebastian F; Targarona, Eduardo M; Mattioli, Sandro
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial
2006-01-01 D, Santini; F, Graziano; V, Catalano; M, DI SERI; E, Testa; Am, Baldelli; P, Giordani; A, LA CESA; B, Spalletta; B, Vincenzi; A, Russo; M, Caraglia; V, Virzi; Cascinu, S.; G, Tonini
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
2008-01-01 Van Cutsem, E.; Van de Velde, C.; Roth, A.; Lordick, F.; Kohne, C. -H.; Cascinu, S.; Aapro, M.
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II tria
2008-01-01 Cascinu, S; Berardi, R; Labianca, R; Siena, S; Falcone, A; Aitini, E; Barni, S; Di Costanzo, F; Dapretto, E; Tonini, G; Pierantoni, C; Artale, S; Rota, S; Floriani, I; Scartozzi, M; Zaniboni, A; Italian Group for the Study of Digestive Tract Cancer, (GISCAD)
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
2007-01-01 A, SARTORE-BIANCHI; M, Moroni; S, Veronese; C, Carnaghi; E, Bajetta; G, Luppi; A, Sobrero; C, Barone; Cascinu, S.; G, Colucci; E, Cortesi; M, Nichelatti; M, Gambacorta; S, Siena
Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
2007-01-01 Scartozzi, M.; Bearzi, I.; Berardi, R.; Mandolesi, A.; Pierantoni, C.; Cascinu, S.
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
2009-01-01 Scartozzi, M.; Bearzi, I.; Mandolesi, A.; Pierantoni, C.; Loupakis, F.; Zaniboni, A.; Negri, F.; Quadri, A.; Zorzi, F.; Galizia, E.; Berardi, R.; Biscotti, T.; Labianca, R.; Masi, G.; Falcone, A.; Cascinu, S.
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy
2009-01-01 Peeters, M; Siena, S; Van Cutsem, E; Sobrero, A; Hendlisz, A; Cascinu, S; Kalofonos, H; Devercelli, G; Wolf, M; Amado, Rg
Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review
2009-01-01 Berardi, R.; Verdecchia, L.; Paolo, M. D.; Giampieri, R.; Scartozzi, M.; Pierantoni, C.; Bianconi, M.; Mazzanti, P.; Cascinu, S.
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2
2009-01-01 Berardi, R.; Maccaroni, E.; Onofri, A.; Giampieri, R.; Pistelli, M.; Bittoni, A.; Scartozzi, M.; Pierantoni, C.; Mandolesi, A.; Bearzi, I.; Cascinu, S.
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
2010-01-01 Loupakis, F.; Masi, G.; Fornaro, L.; Vasile, E.; Allegrini, G.; Fontana, E.; Granetto, C.; Salvatore, L.; Mentuccia, L.; Andreuccetti, M.; Cortesi, E.; Merlano, M.; Cascinu, S.; Falcone, A.
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
2010-01-01 Cascinu, S; Galizia, E; Labianca, R; Ferraù, F; Pucci, F; Silva, Rr; Luppi, G; Beretta, Gd; Berardi, R; Scartozzi, M
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
2010-01-01 Scartozzi, M.; Mazzanti, P.; Giampieri, R.; Berardi, R.; Galizia, E.; Gasparini, S.; Zuccatosta, L.; Cascinu, S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39390
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711477
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...517
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer361
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28797
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33610
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1